Introduction {#S0001}
============

Very low birth weight (VLBW) infants comprise between 4-8% of live-births but about one-third of deaths during the neonatal period occur in this group of newborns^\[[@CIT0001]\ ,\ [@CIT0002]\]^. Although, recent advances in medical technology and innovations in the quality of care for premature neonates have resulted in increasing life expectancy for these small infants, especially for babies weighing under 1000 grams at birth (ELBW infants) during the last two decades, frequency of complications associated with premature birth have remained stationary^\[[@CIT0003]\]^. Studies have reported normal outcomes in approximately 73% of these preterm neonates, figures vary widely from country to country with reports of up to 90% survival from developed countries to 40% in the developing world^\[[@CIT0004]\]^.

Normal outcomes with no or minimal complications in a VLBW infant depend largely on the quality of prenatal and perinatal care. The aim of this study is to determine the frequency of disease, rate of survival, complications and risk factors for morbidity and mortality in VLBW neonates admitted to a level III neonatal intensive care unit at Mahdieh Hospital in Tehran.

Subjects and Methods {#S0002}
====================

This cross-sectional retrospective study was performed for duration of 3 years from April 2007 to March 2010 in the NICU of Mahdieh Hospital in Tehran, Iran. This center is teaching hospital of Shahid Beheshti University of Medical Sciences in south Tehran with 40 level III NICU cuds, and more than 95% inborn admissions and about 5000 deliveries per year.

All VLBW neonates hospitalized in the NICU of this hospital were enrolled in the study including those with congenital anomalies. We excluded infants with birth weight less than 500 grams, death within 12 hours of life and multiple congenital anomalies incompatible with life.

All relevant pre- and peri-natal data was collected from the case notes, and together with all information from the time of birth, admission to the NICU, hospital course up to the time of discharge from the hospital or death was documented on a pre-designed questionnaire. In our center CPR team are present in delivery room for all VLBW neonates, CPR is performed in accordance with the NRP algorithm^\[[@CIT0012]\]^, if developed RDS, NCPAP was applied by Neopuffor, the neonate intubated and transferred to the NICU, no surfactant was administered in delivery room. In NICU spontaneously breathing neonates received NCPAP (PEEP 4-6 cmH2O, FIO2 \< 0.4). If failure happened (need for PEEP \>6cmH2O or FIO2 \>0.4, respiratory distress, ABG deterioration and SPO2 \<85%) INSURE was done. Mechanical ventilation was started in those with poor respiratory effort at birth and those with NCPAP and INSURE failure (PEEP \>6cmH2O, FIO2 \>0.6 and PIP \>14cmH2O).

All complications during the course of hospitalization were recorded. Retinopathy of prematurity (ROP) was diagnosed by a single ophthalmologist with indirect ophthalmoscopic examination at bedside according to AAP guide line (at age 4-6 weeks) and classified according to the international criteria for retinopathy^\[[@CIT0005]\]^, Chronic lung disease (CLD) was diagnosed if the infant continued to need oxygen by the 28th postnatal day or at 36 weeks after the mother\'s last menstrual period^\[[@CIT0001]\]^. Necrotizing enterocolitis (NEC) was diagnosed on compatible clinical, laboratory and radiological manifestations according to the modified Bell criteria^\[[@CIT0006]\]^. Bed-side intracranial sonography was done through the anterior fontanel by a single radiologist on days 3, 7, 14 and 28 to detect intra-ventricular hemorrhage (IVH), the severity of which was classified in accordance with Papile staging^\[[@CIT0007]\]^; if necessary, the sonography was repeated every week till discharge from the hospital. After documentation, data from newborns who survived were compared with those who died.

Categorical data were reported as count and percentage and continuous data as mean±standard deviation (SD). To detect mortality risk factors we performed simple and multiple logistic regressions, and odds ratio (OR) with related 95% confidence interval (95%CI) were reported. *P*-values less than 0.05 considered as statistically significant.

Findings {#S0003}
========

During a period of 3 years 13197 neonates were delivered in the Mahdieh Hospital; 564 (4.3%) were VLBW and 51.4% males. Mean gestational age was 29.6±2.5 weeks; mean birth weight was 1179±257 grams. Average duration of hospitalization was 29.7±23.6 days ([Table 1](#T0001){ref-type="table"}).

###### 

Demographic and perinatal characteristics of study population

  Characteristic                                                                                     No. (%)
  --------------------------------------------------- ---------------------------------------------- ----------------
  **Gender**                                          Female                                         274 (48.6%)
  Male                                                290 (51.4%)                                    
  **Birth weight (mean± SD)**                                                                        1179.26±258.04
                                                      \< = 750                                       42 (7.4%)
                                                      751-1000                                       105 (18.6%)
                                                      1001-1250                                      153 (27.1%)
                                                      1251-1500                                      264 (46.8%)
  **Gestational age (Weeks; mean± SD)**                                                              29.68±2.58
                                                      ≤28                                            196 (34.8%)
                                                      29-32                                          301 (53.4%)
                                                      33-36                                          62 (11%)
                                                      ≥ 37                                           5 (0.9%)
  **Delivery mode**                                   Cesarean                                       416 (73.8%)
  Vaginal                                             148 (26.2%)                                    
  **Primigravida**                                    No                                             241 (42.7%)
  Yes                                                 323 (57.3%)                                    
  **Plurality**                                       Singleton                                      334 (59.2%)
  Twin                                                123 (21.8%)                                    
  Triple and more                                     107 (19.0%)                                    
  **Place of birth**                                  Inborn                                         471 (83.5%)
  Outborn                                             93 (16.5%)                                     
  **Maternal age (Years; mean± SD)**                                                                 28.27±6.03
  **Antenatal steroid**                                                                              562 (99.6%)
  **Maternal disease**                                                                               332 (58.9%)
  **Preeclampcia**                                                                                   125 (22.2%)
  **Premature rupture of membranes**                                                                 49 (8.7%)
  **Prolonged labor**                                                                                33 (5.9%)
  **Infertility**                                                                                    133 (23.6%)
  **Chorioamnionitis**                                                                               11 (2%)
  **Abruption placenta**                                                                             59 (10.5%)
  **Apgar score at one minute (mean± SD)**                                                           6.36±2.07
  **Apgar score at five minute (mean± SD)**                                                          7.86±1.7
  **Apgar score**                                     ≥6                                             388 (68.8%)
  \<6                                                 176 (31.2%)                                    
  **Resuscitation at birth**                                                                         246 (43.6%)
  **Surfactant therapy**                                                                             366 (64.9%)
  **Mechanical ventilation only**                                                                    38 (6.7%)
  **Duration of mechanical ventilation (mean± SD)**                                                  0.56±4.02
  **Duration of hospital stay (mean± SD)**                                                           29.72±23.60
  **Age at time of discharge.median (Min-Max)**                                                      32d; (1-185d)
  **Age at time of death, median (Min-Max)**                                                         4d; (1-75d)
  **Outcome**                                         Age of regain birth weight; Median (Min-Max)   15d; (1-84d)
  Survive                                             400 (70.9%)                                    
  Death                                               164 (29.1%)                                    

Average birth weight of babies who survived was significantly higher than of those who died, (1275±189 vs. 944±253 grams respectively; *P*\<0.001); similar pattern was noticed for gestational age (30.5±2.2 vs. 27.5±2 weeks, respectively; *P*\<0.001); and also for the mean Apgar scores, (6.9±1.7 vs. 5±2.1; *P*\<0.001). In contrast, need for resuscitation was significantly higher in the latter group, *P*\<0.001 ([Table 2](#T0002){ref-type="table"}).

###### 

Antenatal and perinatal risk factors (variables) in dead and alive neonates

  Parameter                           Characteristic   Alive (n = 400)   Dead (n = 164)   OR       95%CI          *P*. Value
  ----------------------------------- ---------------- ----------------- ---------------- -------- -------------- ------------
  **Gender**                          Female           201 (73.4%)       73 (26.6%)       1        0.87-1.81      0.2
  Male                                199 (68.6%)      91 (31.4%)        1.26                                     
  **Birth weight (gm)**                                1275.53(189.15)   944.45(253.37)   0.54                    
                                      \< = 750         3 (7.1%)          39 (92.9%)       167.63   0.48-0.6       \<0.001
                                      751-1000         46 (43.8%)        59 (56.2%)       16.54    47.38-593.14   \<0.001
                                      1001-1250        106 (69.3%)       47 (30.7%)       5.72     9.03-30.3      \<0.001
                                      1251-1500        245 (92.8%)       19 (7.2%)        1        3.2-10.21      \<0.001
  **Gestational age (w)**                              30.55(2.25)       27.56(2.03)      0.49                    
                                      =28              72 (36.7%)        124 (63.3%)      6.89     0.43-0.56      \<0.001
                                      29-32            264 (87.7%)       37 (12.3%)       0.56     0.76-62.83     0.09
                                      33-36            60 (96.8%)        2 (3.2%)         0.13     0.06-5.15      0.6
                                      = 37             4 (80%)           1 (20%)          1        0.01-1.8       0.1
  **Gestational age**                 \<28w            27 (24.5%)        83 (75.5%)       14.16    8.62-23.25     \<0.001
  ≥28w                                373 (82.2%)      81 (17.8%)                                                 
  **Delivery mode**                   Cesarean         314 (75.5%)       102 (24.5%)      1        1.49-3.3       \<0.001
  Vaginal                             86 (58.1%)       62 (41.9%)        2.22                                     
  **Primigravida**                    Yes              230 (71.2%)       93 (28.8%)       0.97     0.67-1.4       0.9
  No                                  170 (70.5%)      71 (29.5%)                                                 
  **Plurality**                       Singleton        233 (69.8%)       101 (30.2%)      1        0.6-1.26       0.5
  Multiple                            167 (72.6%)      63 (27.4%)        0.87                                     
                                      Maternal age     28.26(5.61)       28.3(6.98)       1        0.97-1.03      0.9
  **Maternal age**                    \<20yrs          15 (60%)          10 (40%)         1.67     0.73-3.79      0.2
  ≥20yrs                              385 (71.4%)      154 (28.6%)                                                
  **Maternal disease**                Yes              242 (72.9%)       90 (27.1%)       0.79     0.55-1.15      0.2
  No                                  158 (68.1%)      74 (31.9%)                                                 
  **Preeclampcia**                    Yes              100 (80%)         25 (20%)         0.54     0.33-0.87      0.01
  No                                  300 (68.3%)      139 (31.7%)                                                
  **PROM**                            Yes              40 (81.6%)        9 (18.4%)        0.52     0.25-1.1       0.09
  No                                  360 (69.9%)      155 (30.1%)                                                
  **Prolonged labor**                 Yes              28 (84.8%)        5 (15.2%)        0.42     0.16-1.1       0.08
  No                                  372 (70.1%)      159 (29.9%)                                                
  **Infertility**                     Yes              92 (69.2%)        41 (30.8%)       1.12     0.73-1.7       0.6
  No                                  308 (71.5%)      123 (28.5%)                                                
  **Chorioamnionitis**                Yes              3 (27.3%)         8 (72.7%)        6.79     1.78-25.91     0.005
  No                                  397 (71.8%)      156 (28.2%)                                                
  **Abruption placenta**              Yes              37 (62.7%)        22 (37.3%)       1.52     0.87-2.67      0.1
  No                                  363 (71.9%)      142 (28.1%)                                                
  **Meconium stain amniotic fluid**   Yes              11 (68.8%)        5 (31.3%)        1.11     0.38-3.25      0.8
  No                                  389 (71%)        159 (29%)                                                  
  **Apgar score at five minute**                       6.91(1.78)        5.02(2.13)       0.53     0.46-0.6       \<0.001
  **Apgar score (5')**                ≥6               317 (81.7%)       71 (18.3%)       1        3.38-7.41      \<0.001
  \<6                                 83 (47.2%)       93 (52.8%)        5                                        
  **Resuscitation at birth**          Yes              126 (51.2%)       120 (48.8%)      5.93     3.96-8.89      \<0.001
  No                                  274 (86.2%)      44 (13.8%)                                                 
  **Intubation at delivery room**     Yes              18 (26.1%)        51 (73.9%)       9.58     5.38-17.05     \<0.001
  No                                  382 (77.2%)      113 (22.8%)                                                

CI: Confidence Interval

On simple regression analysis, co-morbidities and complications associated with a rise in mortality included respiratory distress syndrome, (RDS), pneumothorax, pulmonary hemorrhage, CLD, repeated seizures, IVH, renal failure, gastrointestinal bleeding, anemia, homeostatic imbalance and metabolic abnormalities; while treatment modalities revealed as risk factors associated with increase in mortality were surfactant replacement therapy, nasal continuous positive airway pressure, (NCPAP), INSURE, (INtubation SURfactant Extubation), and mechanical ventilation ([Table 3](#T0003){ref-type="table"}).

###### 

Mortality rates according to the disease/treatment characteristics in neonatal period

                                                        Characteristic   Alive (n = 400)   Dead (n = 164)   OR      95%CI         p-Value
  ----------------------------------------------------- ---------------- ----------------- ---------------- ------- ------------- ---------
  **Respiratory distress syndrome**                     Yes              252 (62.2%)       153 (37.8%)      8.17    4.29-15.56    \<0.001
  No                                                    148 (93.1%)      11 (6.9%)                                                
  **Surfactant therapy**                                Yes              229 (62.6%)       137 (37.4%)      3.79    2.4-5.99      \<0.001
  No                                                    171 (86.4%)      27 (13.6%)                                               
  **Intubation-Surfactant-Extubation**                  Yes              123 (85.4%)       21 (14.6%)       0.33    0.2-0.55      \<0.001
  No                                                    277 (66%)        143 (34%)                                                
  **Nasal continuous positive airway pressure**         Yes              166 (76.5%)       51 (23.5%)       0.64    0.43-0.94     0.02
  No                                                    234 (67.4%)      113 (32.6%)                                              
  **Mechanical ventilation**                            Yes              19 (50%)          19 (50%)         2.63    1.35-5.1      0.004
  No                                                    381 (72.4%)      145 (27.6%)                                              
  **Mechanical Ventilation + Surfactant**               Yes              134 (50.2%)       133 (49.8%)      8.52    5.47-13.26    \<0.001
  No                                                    266 (89.6%)      31 (10.4%)                                               
  **Patent Ductus Arteriosus**                          Yes              131 (71.6%)       52 (28.4%)       0.95    0.65-1.41     0.81
  No                                                    269 (70.6%)      112 (29.4%)                                              
  **Necrotizing enterocolitis ≥2**                      Yes              3 (50%)           3 (50%)          2.47    0.49-12.35    0.27
  No                                                    397 (71.1%)      161 (28.9%)                                              
  **Intra-ventricular hemorrhage (All Grade)**          Yes              139 (73.5%)       50 (26.5%)       2.78    1.24-6.24     0.01
  No                                                    261 (69.6%)      114 (30.4%)                                              
  **Periventricular leukomalacia**                      Yes              4 (57.1%)         3 (42.9%)        1.84    0.41-8.33     0.43
  No                                                    396 (71.1%)      161 (28.9%)                                              
  **Pneumothorax**                                      Yes              20 (35.1%)        37 (64.9%)       5.54    3.1-9.89      \<0.001
  No                                                    380 (75%)        127 (25%)                                                
  **Pulmonary hemorrhage**                              Yes              16 (17.4%)        76 (82.6%)       20.73   11.53-37.27   \<0.001
  No                                                    384 (81.4%)      88 (18.6%)                                               
  **Chronic Lung Disease**                              Yes              84 (81.6%)        19 (18.4%)       0.49    0.29-0.84     0.01
  No                                                    316 (68.5%)      145 (31.5%)                                              
  **Renal failure**                                     Yes              42 (47.7%)        46 (52.3%)       3.32    2.08-5.3      \<0.001
  No                                                    358 (75.2%)      118 (24.8%)                                              
  **Seizure**                                           Yes              36 (37.9%)        59 (62.1%)       5.68    3.56-9.07     \<0.001
  No                                                    364 (77.6%)      105 (22.4%)                                              
  **Gastrointestinal bleeding**                         Yes              11 (29.7%)        26 (70.3%)       6.66    3.21-13.84    \<0.001
  No                                                    389 (73.8%)      138 (26.2%)                                              
  **Apnea**                                             Yes              155 (73.5%)       56 (26.5%)       0.82    0.56-1.2      0.31
  No                                                    245 (69.4%)      108 (30.6%)                                              
  **Infection (Pneumonia +/- Meningitis +/- Sepsis)**   Yes              106 (71.1%)       43 (28.9%)       0.99    0.65-1.49     0.95
  No                                                    294 (70.8%)      121 (29.2%)                                              
  **Anemia**                                            Yes              211 (82.7%)       44 (17.3%)       0.33    0.22-0.49     \<0.001
  No                                                    189 (61.2%)      120 (38.8%)                                              
  **Hematologic complication**                          Yes              232 (75.8%)       74 (24.2%)       0.6     0.41-0.86     0.006
  No                                                    168 (65.1%)      90 (34.9%)                                               
  **Metabolic complication**                            Yes              258 (66.3%)       131 (33.7%)      2.18    1.42-3.37     \<0.001
  No                                                    142 (81.1%)      33 (18.9%)                                               
  **Surgical operation**                                Yes              9 (69.2%)         4 (30.8%)        1.09    0.33-3.58     0.89
  No                                                    391 (71%)        160 (29%)                                                

CI: Confidence Interval

On multiple regression analysis, lower birth weight, need for mechanical ventilation, pulmonary hemorrhage and gastro-intestinal bleeding remained as factors significantly associated with the risk of mortality. Other variables associated with the risk of neonatal death were, maternal pre-eclampsia or hemorrhage, vaginal delivery, Apgar \<6 at 5 minutes, need for intubation at birth, NCPAP, surfactant replacement therapy, CLD, intractable seizures and hematological abnormalities, ([Table 4](#T0004){ref-type="table"}).

###### 

Multiple regression analysis with adjusted estimates of odds ratio (95% CI)

  Characteristic                                              OR      95%CI          *P*. Value
  ------------------------------------------- --------------- ------- -------------- ------------
  **Birth weight (gm)**                       **\< = 750**    11.09   3.83-32.08     \<0.001
                                              **751-1000**    63.53   17.07-236.45   \<0.001
                                              **1001-1250**   11.09   3.83-32.08     \<0.001
                                              **1251-1500**   1                      
  **Vaginal delivery mode**                                   2.55    1.05-6.18      0.04
  **Preeclampcia**                                            0.34    0.12-0.95      0.04
  **Maternal Bleeding(placenta abruption)**                   5.18    1.41-19.07     0.01
  **Apgar score \<6 in 5 minute**                             3.51    1.41-8.73      0.007
  **Intubation at delivery room**                             3.52    1.04-11.94     0.04
  **nCPAP**                                                   0.27    0.11-0.63      0.003
  **Mechanical ventilation +Surfactant**                      47.08   14.35-154.42   \<0.001
  **Mechanical ventilation only**                             35.75   6.56-194.77    \<0.001
  **Pulmonary hemorrhage**                                    45.57   14.38-144.41   \<0.001
  **Chronic Lung Disease**                                    0.05    0.02-0.16      \<0.001
  **Gastrointestinal bleeding**                               11.66   3.03-44.88     \<0.001
  **Seizure**                                                 3.82    1.42-10.24     0.008
  **Hematologic complication**                                0.12    0.05-0.31      \<0.001

CI: Confidence Interval; nCPAP: Nasal continuous positive airway pressure

Overall survival was 70.9%; in ELBW newborns this figure was 33.3% rising to 84.1% in infants weighing between 1001-1500 grams. Respiratory failure resulting from RDS in babies with extremely low birth weight was the major factor leading to death ([Tables 5](#T0005){ref-type="table"} and [6](#T0006){ref-type="table"}).

###### 

Overall survival and survival with selected complication among VLBW according to birth weight

  Characteristic                         Birth weight groups                                                        
  -------------------------------------- --------------------- ---------------- ----------------- ----------------- -----------------
  **Outcome**                            501-750               751 -1000        1001 -1250        1251-1500         Total (n = 400)
  **Overall survival**                   3.42                  46.105 (43.8%)   106.153 (69.3%)   245.264 (92.8%)   400.564 (70.9%)
                                         (7.1%)                (43.8%)          (69.3%)           (92.8%)           (70.9%)
  **Survival without complication**      2 (66.7%)             21 (45.7%)       71 (67%)          204 (83.3%)       298 (74.5%)
  **Survival with complication**                                                                                    
  ** CLD**                               1 (33.3%)             23 (50%)         32 (30.2%)        28 (11.4%)        84 (21.0%)
  ** Intra-ventricular hemorrhage ≥3**   0 (0%)                2 (4.3%)         4 (3.8%)          6 (2.4%)          12 (3.0%)
  ** NEC ≥2**                            0 (0%)                1 (2.2%)         1 (0.9%)          1 (0.4%)          3 (0.8%)
  **Sever ROP (treated by laser)**       1 (33.3%)             10 (21.7%)       14 (13.2%)        8 (3.3%)          33 (8.3%)

###### 

Distribution of died babies in relation of birth weight and primary cause of death

  Characteristic             Birth weight groups                                          
  -------------------------- --------------------- ------------ ------------ ------------ ----------------
  **Cause of death**         501-750               751 -1000    1001 -1250   1251-1500    Total(n = 164)
  **Respiratory failure**    30 (76.9%)            47 (79.7%)   32 (68.1%)   13 (68.4%)   122 (74.4%)
  **Sepsis**                 2 (5.1%)              0 (0%)       1 (2.1%)     1 (5.3%)     4 (2.4%)
  **Congenital anomalies**   0 (0%)                0 (0%)       1 (2.1%)     1 (5.3%)     2 (1.2%)
  **Others**                 7 (17.9%)             12 (20.3%)   13 (27.7%)   4 (21.1%)    36 (22.0%)

Discussion {#S0004}
==========

Prevalence of VLBW neonates (4.3%) and ELBW infants (1,1%) in our study is comparable to reports from other countries; world-wide prevalence of VLBW babies has been reported between 5-7% and that of ELBW as 1%; however, studies from the United States set the figures at 1.1% and 0.7% respectively^\[[@CIT0001]\ ,\ [@CIT0008]\]^. This study was done in a level III NICU in a hospital that is a referral center for high risk pregnancies, therefore, our figures are not representative of nation-wide prevalence of very low birth weight infants, that is about 0.98% in our country with birth rate of 1.3% and NMR around 17/1000 live births according to UNICEF report at 2009.

Maternal co-morbidities are linked with neonatal morbidity and mortality^\[[@CIT0009]\ ,\ [@CIT0010]\]^; in the present study 58.9% of mothers were considered at high risk because of pregnancy-associated complications including pre-eclampsia (22.2%) abruptio placentae (10.5%), infertility (23.6%), PROM (8.7%), prolonged labor (5.9%) and chorioamnionitis (2%) ([Table 1](#T0001){ref-type="table"}).

Optimal mode of delivery for VLBW neonates is controversial but most authorities regard cesarean section as the method of choice for these infants^\[[@CIT0011]\]^; however, 26.2% of our patients had been delivered normally with increased mortality rate (41.9% vs 24.5%) and NVD was an independent risk factor for neonatal mortality ([Table 4](#T0004){ref-type="table"}).

Team of personnel well-trained in recognition of need to resuscitate and prompt appropriate measures to establish adequate respiration is crucial for survival of VLBW infants with minimal long and short term complications. One and five minute Apgar scores are generally used to assess the respiratory status of the newborn and to define the outcome for cardio-pulmonary resuscitation^\[[@CIT0012]\]^. An Apgar score of \<6 at 5 minutes, which is a risk factor for neonatal mortality, was observed in approximately onethird (31.2%) of the VLBW infants in our study; in a 10-year research performed in USA by Daksha et al, 46.9% of VLBW newborns had an Apgar score of \<6 at 5 minutes^\[[@CIT0014]\]^. This difference may be due to lower gestational age and birth weight infants in Daksha study or our successful resuscitation in delivery room.

During the last few years Delivery Room Cardio- Pulmonary Resuscitation, (DR-CPR) has named for advanced resuscitation (intubation, chest compression and adrenaline administration) of VLBW infants. 82.1% of Finer\'s 27707 newborns in 196 neonatal units needed chest compression and 66.7% adrenaline administration, 63.3% survived^\[[@CIT0014]\]^. In our study out of 69 infants that had needed endotracheal intubation 51 (73.9%) died later during hospital course showing that improvement of quality of post-resuscitation care is needed in our NICU.

RDS has been reported to occur in up to 90% of VLBW infants^\[[@CIT0015]\]^, this was 71.8% in our study which is acceptable due to the higher gestational age of our infants. Optimal management requires teamwork between obstetricians and neonatologists and includes meticulous prenatal care, timely administration of steroids, planned delivery in a center equipped with a level III NICU, presence of trained resuscitation team in the delivery unit, initiation of NCPAP at birth, prompt administration of surfactant (INSURE) and mechanical ventilation if needed^\[[@CIT0016]\]^. We followed this recommended guidelines in 405 of our patients who developed RDS, with NCPAP (in 53.6%) and INSURE (in 35.5%); however, we had to start mechanical ventilation in 267 (65.9%) of these newborns. Despite these measures 153 (37.8%) died, this underlines the severity of RDS in our patients, although NCPAP and INSURE failure was compatible with some other studies^\[[@CIT0017]--[@CIT0020]\]^, NCPCP and mechanical ventilation (with or without surfactant) were independent risk factors for neonatal mortality ([Table 4](#T0004){ref-type="table"}).

Short term complications seen in our surviving patients included CLD in 21%, ROP in 8.3%, IVH in 3% and NEC in 0.8%. Prevalence of CLD was comparable to the figures quoted in other studies from the industrialized countries, but the other complications were lower than reported in other studies^\[[@CIT0001],\ [@CIT0003],\ [@CIT0004],\ [@CIT0015],\ [@CIT0021],\ [@CIT0022]\]^, which may be due to more mature neonates in our study and respecting the standard care for prevention of ROP, IVH and NEC.

In multiple regression analysis, pulmonary hemorrhage, gastrointestinal bleeding, seizures, hematologic complications were also independent risk factors for neonatal mortality ([Table 4](#T0004){ref-type="table"}), which are similar in one or more complications compared with other studies, however, In most studies very low birth weight and need for mechanical ventilation have been quoted as risk factors for mortality^\[[@CIT0015],\ [@CIT0025]\]^, the same as in our study.

Rate of overall survival for VLBW newborns has been widely different in studies from different parts of the world; 63% from India ^\[[@CIT0023]\]^, 35.6% from a study in Iran^\[[@CIT0024]\]^, 70% and 71% in 2006 and 2003 from South Africa^\[[@CIT0025]\]^, 74.5% from Turkey ^\[[@CIT0026]\]^, 81% from Thailand^\[[@CIT0021]\]^, 87.5 and 85% from the USA^\[[@CIT0027],\ [@CIT0028]\]^, 84% from Spain^\[[@CIT0029]\]^, and 90% from New Zealand and the Netherlands^\[[@CIT0030],\ [@CIT0031]\]^. Survival of ELBW infants in our study was 33.3% while it has been reported as 34.9% from South Africa^\[[@CIT0025]\]^, 36.6% in an Iranian study^\[[@CIT0032]\]^, 44% from Italy^\[[@CIT0033]\]^, and 51.8% from the United States^\[[@CIT0028]\]^. These differences mainly related to gestational age, birth weight and associated diseases of the newborns and standard care of NICU in different studies.

Neonates weighing ≤750 grams at birth had the highest mortality rate; only 3 out of 42 (7.1%) infants in this group survived; this figure is comparable to studies from other developing countries^\[[@CIT0001],\ [@CIT0002]\]^. due to limited facilities and NICU bed. Similar to other studies^\[[@CIT0025],\ [@CIT0030],\ [@CIT0034]\]^ main cause of mortality in our patients was RDS leading to respiratory failure; sepsis and major congenital anomalies were also common causes of death, which need improving quality of care in our NICU with available facilities.

Limitations of our study were: 1) retrospective study, 2) limited to short term outcome during hospital course, 3) lack of neonatal network in our NICU.

Conclusion {#S0005}
==========

Our findings reveal that birth weight and mechanical ventilation are the 2 major factors responsible for mortality. Although survival of VLBW infants in our study is comparable to other studies around the world, a decline in the mortality and mobidity of these newborns (especially the ELBW neonates) can only be made possible through optimizing perinatal care including regionalization, CPR at birth, early NCPAP and quality improved collaborative (QIC) in our NICU.
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